MOSES LAKE, Wash. (AP) — A subsidiary of a Japanese pharmaceutical company plans to build a manufacturing facility in central Washington to produce a food supplement.
Natural astaxanthin is an algae-based product that is an anti-inflammatory agent.
The Columbia Basin Herald reported Monday that AstaReal Technologies will build a $30 million plant to produce natural astaxanthin on a 10-acre parcel of land in Moses Lake. The company is a subsidiary of Fuji Chemical Industry.
The plant will employ up to 45 people once it begins operating late in 2014. The company says most of those workers will be hired locally next year.